IDBS, a provider of enterprise scientific informatics platforms has announced a new SaaS contract with Genevant Sciences Corporation, a leading biopharmaceutical company focused on the discovery and development of a broad range of RNA-based therapeutics across multiple modalities.
IDBS, a provider of enterprise scientific informatics platforms, has announced the appointment of Graeme Dennis as Pre-Clinical Pharma commercial director, Abhay Kini as director of product management and April Pisek as solutions consultant
IDBS has announced that Christian Marcazzohas joined the company as Vice President and General Manager
Data types used are advancing from the simple text formats of old, writes Paul Denny-Gouldson
Robert Roe interviews laboratory informatics software providers who discuss potentially disruptive technologies and their impact on the laboratory informatics market
For research and development (R&D) organisations, the rise of instrument and process automation is leading to a phenomenal increase in the amount, variety and complexity of scientific data that is gathered
IDBS has announced the release of its latest Bioprocess Execution (BPES) informatics solution with cloud integration
IDBS, a provider of scientific informatics platforms and software has announced it has been acquired by the Danaher corporation
After The E-WorkBook Cloud launch earlier this year, IDBS has now enhanced its capabilities by adding a pre-qualified service to the suite, which has been designed to help organisations streamline their compliance processes for good practice (GxP) regulated systems. We call it The E-WorkBook GxP Cloud.
For functionality and security for externalised research, software providers have turned to the cloud, writes Sophia Ktori
Drug development is facing change – both from technological pressures, such as the use of AI and machine learning, plus new regulations which are driving sweeping changes to the way electronic records are created and stored for clinical trials.
Robert Roe speaks with laboratory informatics software providers about the future of their software and the introduction of new technologies, such as AI and deep learning
Scientists are now beginning to use new technologies such as the internet of things (IoT), artificial intelligence (AI) and machine learning (ML) in their daily workflows.
In today’s world, where drug development integrates science and technology, consumer safety is paramount in the pharmaceutical industry.
